Next Article in Journal
Effect of a Whey Protein Supplement on Preservation of Fat Free Mass in Overweight and Obese Individuals on an Energy Restricted Very Low Caloric Diet
Next Article in Special Issue
Hypertension Associated with Fructose and High Salt: Renal and Sympathetic Mechanisms
Previous Article in Journal
Effects of Protein Supplementation Combined with Exercise Intervention on Frailty Indices, Body Composition, and Physical Function in Frail Older Adults
Previous Article in Special Issue
Cod Residual Protein Prevented Blood Pressure Increase in Zucker fa/fa Rats, Possibly by Inhibiting Activities of Angiotensin-Converting Enzyme and Renin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 10
Issue 12
10.3390/nu10121917
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension

by
Chien-Ning Hsu
1,2 and
You-Lin Tain
3,4,*
1
Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
2
School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3
Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
4
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(12), 1917; https://doi.org/10.3390/nu10121917
Submission received: 20 October 2018 / Revised: 22 November 2018 / Accepted: 30 November 2018 / Published: 4 December 2018
(This article belongs to the Special Issue Nutrients Intake and Hypertension)
Browse Figure
Versions Notes

Abstract

:
Hypertension is a growing global epidemic. Developmental programming resulting in hypertension can begin in early life. Maternal nutrition status has important implications as a double-edged sword in the developmental programming of hypertension. Imbalanced maternal nutrition causes offspring’s hypertension, while specific nutritional interventions during pregnancy and lactation may serve as reprogramming strategies to reverse programming processes and prevent the development of hypertension. In this review, we first summarize the human and animal data supporting the link between maternal nutrition and developmental programming of hypertension. This review also presents common mechanisms underlying nutritional programming-induced hypertension. This will be followed by studies documenting nutritional interventions as reprogramming strategies to protect against hypertension from developmental origins. The identification of ideal nutritional interventions for the prevention of hypertension development that begins early in life will have a lifelong impact, with profound savings in the global burden of hypertension.

1. Introduction

Hypertension remains an important public health challenge, despite treatment advances over the past decades. However, hypertension is a disease of multifactorial origins that can be treated to prevent more related disorders if found early. Although hypertension is more common in adults, it can occur at any age. Indeed, adult-onset hypertension can originate in early life [1]. Maternal nutrition during pregnancy and lactation has important implications for optimal fetal development and long-term health of the offspring. Imbalanced maternal nutrition produces fetal programming that permanently alters the body’s morphology and function and leads to many adult diseases, including hypertension [2]. This notion is framed as the developmental origins of health and disease (DOHaD) [3]. Conversely, the DOHaD concept leads to a shift in the therapeutic approach from adult life to early stage, before hypertension is evident. This strategy reversing the programming processes in fetal and infantile life is known as reprogramming [4]. Nutrition interventions have recently started to gain importance as a reprogramming strategy to prevent hypertension of developmental origins [4,5,6].
According to the two aspects of the DOHaD concept, maternal nutrition may play an important role as a double-edged sword in developmental programming of hypertension. This review will first present the clinical and experimental evidence for how maternal undernutrition and overnutrition trigger the programming mechanisms leading to programmed hypertension. This will be followed by potential nutritional interventions that may serve as a reprogramming strategy to halt the growing epidemic of hypertension. A schematic summarizing the links between maternal nutrition, early-life insults, and mechanisms underlying programming of hypertension is presented in Figure 1.

2. Evidence for Programming of Hypertension Related to Maternal Nutrition Status in Humans

Epidemiologic studies support that malnutrition during gestation and lactation has lifelong consequences on adult offspring’s health. A well-known example comes from the Dutch Hunger Winter Families study [7]. Offspring exposed to maternal famine develop many adult diseases, including hypertension [7,8,9]. Another line of evidence for reinforcement comes from observations of malnutrition leading to preterm birth. Epidemiologic studies now support that preterm birth is a key risk factor for hypertension in later life [10]. A meta-analysis of 10 studies with 1342 preterm participants shows that preterm birth subjects have modestly higher systolic blood pressure (BP) later in life [11]. Besides, numerous reports indicate that intakes or lack of specific nutrients during pregnancy may increase the risk of preterm birth [12]. Additionally, the risk of programmed hypertension has been examined in mother–child cohorts (Table 1). Several nutritional risks correlated with the elevation of BP in offspring in these cohorts include vitamin D deficiency [13,14], short-term breastfeeding [15], gestational diabetes mellitus [16], excessive gestational weight gain [17,18], macronutrient intake deficiency [19], and undernutrition [9]. It is noteworthy that hypertension can develop in early childhood [13,15,16], but tends to occur in adulthood. All of these observations provide a link between the imbalanced maternal nutrition status and the risk of developing hypertension in later life.
Nevertheless, these cohorts cannot per se directly establish a causal relationship between the maternal nutrition status and hypertension phenotype in offspring. Also, these cohorts do not illuminate molecular mechanisms by which the hypertension phenotype is created. As a consequence of ethical considerations concerning what is feasible or not in human studies, animal models are of great importance. It is obvious that much of our knowledge comes from animal models, which identify that specific types of nutrients may program hypertension phenotypes. The developmental window is critical for nutritional programming, and specific nutrition interventions can be used as reprogramming strategies.

3. Animal Models of Programmed Hypertension Induced by Imbalanced Maternal Nutrition

Excessive or insufficient consumption of a specific nutrient has been linked to developmental programming of hypertension. Here, we mainly summarize some of the rodent studies documenting BP phenotypes in offspring after a variety of nutritional interventions (Table 2) [20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47]. We have restricted this review to nutritional interventions ending before the start of weaning. As shown in Table 2, rats are the most commonly used subjects among the small animal models. Rats reach sexual maturity at approximately 5–6 weeks of age. In adulthood, one rat month is roughly equivalent to three human years [48]. Accordingly, Table 2 lists the timing of developing hypertension measured in rodents with different ages, which can be calculated and translated to humans of a specific age group. It concerns both undernutrition [20,21,22,23,24,25,26,27,28,42,43,44,45,46,47] and overnutrition [30,31,32,33,34,35,36,37,38,39,40]. It is noteworthy that many studies focused only on the male offspring [22,25,26,29,30,31,34,35,38,39,40,41,47].
Dietary nutrients can be divided to macronutrients, micronutrients, and non-essential nutrients. Macronutrients, which provide energy, include carbohydrates, proteins, and fats. Restriction of calories to various degrees (ranging from 30% to 70%) in pregnant dams has been reported to cause hypertension in their adult offspring [20,21,22,23]. Offspring exposed to a more severe degree of caloric restriction are likely to develop hypertension earlier. Rodent models of low protein feeding have been extensively used to study the mechanisms of nutritional programming. Similar to caloric restriction, a greater degree of protein restriction causes an earlier development of hypertension in offspring [24,25,26,27,28]. However, a previous study showed that two divergent low-protein (9%) diet manipulations in rat pregnancy provoked different programming effects on the offspring’s BP [49]. Of note, the balance of protein and other nutrients may be a critical determinant of the long-term effects of maternal low-protein diet on programming of hypertension. Pregnant women are now recommended to eat methyl donor food to reduce adverse birth outcomes [50]. Such methyl donor nutrients include methionine, choline, folic acid, and vitamins B2, B6, and B12. However, we recently found that pregnant rats fed with high methyl-donor diet or methyl-deficient diet resulted in programmed hypertension in their male adult offspring [29].
Fat is another macronutrient. A high-fat diet is a commonly used animal model to induce obesity and related disorders, like hypertension [51]. The observations of maternal high-fat diet-induced hypertension in offspring are varied [52]. Maternal high-fat intake induced responses of BP include an increase [30,31,32] or no change [31,33], mainly depending on sex, age, strain, and diverse fatty acids compositions. Additionally, several studies showed that consumption of high-fructose alone or as a part of diet by rodent mothers induces programmed hypertension in adult offspring [34,35,36,37,38,39]. Fructose is a monosaccharide naturally present in fruits and honey. However, most of the increase in fructose consumption now is derived from high fructose corn syrup and table sugars. A previous report revealed that up to 74% of fructose came from processed foods and beverages other than whole fruits and vegetables [53]. A maternal high-fructose diet is being developed into a commonly used animal model to induce metabolic syndrome of developmental origins [54]. Although most studies have used fructose doses amounting to ~60% of the total energy requirement [36,37,38], evidence indicates that maternal consumption of 10% w/v fructose significantly increases BP in mice offspring after 1 year [39]. On the other hand, several studies used fructose as a part of maternal diet along with fat and salt [35,38,40]. Given that the Western diet is characterized by the intake of high-sugar drinks, high-fat products, and excess salt, it is important to elucidate the interplay between fructose, fat, and salt on the programming of hypertension. Indeed, animal studies examining the combined effects of key components of the Western diet have shown their synergistic effects between fructose, fat, and salt on the elevation of BP in adult offspring [38,55,56].
Besides, sodium, potassium, calcium, magnesium, and other ions are listed with macronutrients as they are required in large quantities. Interestingly, both low- and high-salt diet exposure during pregnancy and lactation have been reported to cause elevated BP in male adult offspring [41]. Maternal calcium-deficient diet increased BP in adult offspring [42], while magnesium-deficient diet did not [43].
Additionally, deficiencies in micronutrients, including trace elements and vitamins, in pregnant mothers are associated with the development of hypertension in their adult offspring [44,45,46,47]. These micronutrients include iron [44,45], vitamin D [46], and zinc [47]. Although vitamin C, E, B6, flavonoids, and coenzyme Q-10 have been shown to lower BP [57], whether deficiencies of these micronutrients on pregnant mothers leading to programmed hypertension in their offspring is still largely unknown. Besides, no studies have been conducted examining the role of deficient non-essential nutrients on programming of hypertension. In the current review, limited information is available about the use of large animals to study nutritional programming induced offspring hypertension. Two reports in cows and sheep showed that maternal undernutrition causes elevation of BP in adult offspring [58,59].

4. Common Mechanisms Underlie Nutritional Programming of Hypertension

Since various nutritional manipulations in gestation and lactation generate very similar outcomes with respect to hypertension in adult offspring in different species, these observations suggest the existence of common mechanisms that may contribute to the pathogenesis of hypertension of developmental origin. So far, programming of hypertension has been attributed to several mechanisms [4,60,61,62,63,64]. Some of these mechanisms that have been previously linked to nutritional programming include low nephron number, oxidative stress, activation of the renin–angiotensin system (RAS), nutrient-sensing signals, gut microbiota, and sex differences. Each will be discussed in turn.

4.1. Low Nephron Number

The kidneys are known to play a decisive role in regulation of BP. There is an increasing body of literature demonstrating the relationship between low nephron number and hypertension, as reviewed elsewhere [65,66]. Renal development in rodents, unlike in humans, continues up to postnatal week 1–2. Therefore, nutritional insults during last third of pregnancy and early lactation periods have been reported to impair nephrogenesis, leading to a reduction in nephron number [61]. As we reviewed elsewhere [67], these nutritional factors include caloric restriction [22], low-protein diet [25,68], high-salt diet [41], low-salt diet [41], vitamin A deficiency [69], and iron deficiency [70]. Maternal protein restriction resulted in reduced nephron number and elevation of BP in adult male offspring, which is related to renal hyperfiltration and activation of the renin–angiotensin system (RAS) [25]. Additionally, maternal iron and zinc deficiencies have also been found to reduce nephron number and increase systolic BP in adult offspring [66]. Conversely, nephron endowment can be unaltered [71], or even increased in response to nutritional programming [72]. These findings suggest that the nutritional programming of hypertension might be not specific to a single factor (i.e., low nephron endowment) and other mechanisms demands further exploration.

4.2. Oxidative Stress

Oxidative stress is an oxidative shift characterized by an imbalance between pro-oxidant molecules and antioxidant defenses. Nitric oxide (NO), a vasodilator and a free radical, is involved in BP control and oxidative stress. NO plays an important role in placental and fetal growth [73]. Early-life redox imbalance may lead to lifelong effects in vulnerable organs leading to hypertension in later life [74]. Offspring born to dams with NO deficiency develop hypertension [75], while restoration of the balance between NO and reactive oxygen species (ROS) was considered as a reprogramming strategy to prevent hypertension of developmental origins [76]. Numerous nutritional interventions have been reported to result in programmed hypertension related to oxidative stress, including caloric restriction [21,22], low protein diet [26], methyl-donor diet [29] high fat intake [30,32,33], high-fructose diet [36], and zinc deficiency diet [47]. Although oxidative stress is unlikely to be attributed to the sole mechanism that increases the vulnerability to later hypertension, it is required to elucidate its interplay with other mechanisms of nutritional programming in determining its impact on hypertension.

4.3. Renin–Angiotensin System

RAS is broadly involved in control of BP and pharmacological blockade of the RAS has been clinically used to treat hypertension. Inactivation of RAS components cause the reduction of nephron number [77]. Several nutritional insults during early life leading to predisposition toward dysregulation of RAS have been reported, including low-protein diet [25,28], high-fat diet [33], high-sucrose diet [34], and high-fructose diet [37]. Conversely, early blockade of the RAS has been reported to reprogram inappropriate activation of the RAS to prevent the developmental programming of hypertension [37,78,79]. These observations support the notion that RAS might be a common mechanism that underlies hypertension of developmental origins. It is noteworthy that blockade of the RAS to prevent the programmed hypertension cannot start as early as two weeks after birth in the rodent models for two reasons. First, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are contraindicated during pregnancy because of their teratogenic effects. Second, blockade of the RAS impairs nephrogenesis and nephrogenesis completes in postnatal weeks 1–2 in rodents.

4.4. Nutrient-Sensing Signals

Nutrient-sensing signaling pathways influence fetal metabolism and development according to maternal nutritional status. Cyclic adenosine monophosphate (AMP)-activated protein kinase (AMPK) and peroxisome proliferator-activated receptors (PPARs) are well-known nutrient-sensing signals [80]. The interplay between AMPK and other nutrient-sensing signals, driven by maternal nutritional interventions were found to regulate PPARs and their target genes, thereby generating programming of hypertension [81]. Several genes involved in oxidative stress are PPAR target genes, such as Nos2, Nos3, Sod2, and Nrf2 [82]. Additionally, PPARγ has been reported to stimulate renin gene expression [83]. Given that the RAS cascade starts with the release of renin from the kidney, it is possible that programmed hypertension is attributed to these PPAR target genes induced oxidative stress and RAS activation. Furthermore, PPARγ can increase several sodium transporters to increase sodium reabsorption, leading to programmed hypertension [84]. Therefore, nutritional insults could affect PPARs and their target genes to induce renal programming leading to programmed hypertension.
Conversely, pharmacological interventions targeting AMPK signaling has been considered as reprogramming strategies to prevent programmed hypertension [85]. Detailed mechanisms that underlie the interactions between maternal nutrition and nutrient-sensing signals and their roles in the programming process toward hypertension of developmental origins, however, remain unclear.

4.5. Gut Microbiota

Gut is the first organ in contact with dietary nutrients. Maternal nutritional insults may cause a microbial imbalance, namely dysbiosis [86]. Dysbiosis in early life has negative effects and may have long-term consequences leading to many adult diseases, including hypertension [86]. Emerging evidence shows that the development of hypertension is correlated with gut microbiota dysbiosis in animal models of hypertension [87,88,89]. Several possible mechanisms have been identified linking the dysbiosis and hypertension, including alterations of microbial metabolite short-chain fatty acids and their receptors, increases of microbiota-derived metabolite trimethylamine-N-oxide, increased sympathetic activity, activation of the RAS, and inhibition of NO as well as hydrogen sulfide [89]. In addition to macro- and micro-nutrients, non-essential nutrients are substances within foods that can have a significant impact on health, for example, dietary fiber. It is noteworthy that consumption of dietary fiber has become one dietary strategy for modulating the microbiota. Our recent report showed that modulation of gut microbiota by prebiotics (i.e., a special form of dietary fiber) or probiotics (i.e., beneficial bacteria in the gut) can prevent maternal high-fructose consumption induced programmed hypertension [90]. Despite recent studies demonstrating that microbiota-targeted therapies can be applied to a variety of diseases [91], their roles on programmed hypertension remain to be identified.

4.6. Sex Differences

There now is a substantial literature indicating that sex differences exist in the developmental programming of hypertension [92,93], showing that males are more prone to hypertension than females. Besides, several above-mentioned mechanisms of renal programming, such as oxidative stress [94] and inappropriate activation of the RAS [95] have been reported to respond to early-life insults in a sex-specific manner. The long-term effects of the same nutritional insult, such as maternal caloric restriction [23], high-fat diet [33], or high-fructose diet [37], can induce various phenotypes on male and female offspring. This difference has led many researchers to target their efforts entirely to one sex, especially to males [22,25,26,29,30,31,34,35,38,39,40,41,47]. Nevertheless, only few studies have investigated the programming response to maternal diet focused on transcriptome profiles of the offspring kidney [96]. In a maternal high-fructose diet model [37], we found renal transcriptome is sex-specific and female offspring are more fructose-sensitive. This is in accord with a report revealing that more genes in the placenta were affected in females than in males under different maternal diets [97]. A previous study has shown that sex-specific placental adaptations are often associated with male offspring developing adult disease while females are minimally affected [98]. However, whether higher sensitivity to nutritional insults is beneficial or harmful for programming effects in female offspring awaits further evaluation.

5. Nutritional Interventions as Reprogramming Strategies to Prevent Programmed Hypertension

Reprogramming strategies to reverse the programming processes that have been employed include nutritional intervention, exercise and lifestyle modification, and pharmacological therapy [4,6]. Nutritional programming is hypothetically bidirectional: supplementing deleterious nutrients or depleting beneficial nutrients in pregnancy and lactation can induce hypertension, whereas programmed hypertension can be mitigated by maternal supplementation of beneficial nutrients. Although various clinical practice guidelines have been established to provide appropriate therapies for hypertensive disorders of pregnancy [99], less attention has been paid to focus on nutritional interventions. On the other hand, supplementation with macro- and micro-nutrients during pregnancy and lactation periods has been recommended to improve maternal and birth outcomes [100,101]. However, little is known whether supplementing with specific nutrition in early life can be beneficial on programmed hypertension induced by diverse early-life insults in humans. Thus, this review will restrict to nutritional interventions as reprogramming strategies to prevent hypertension of developmental origins in a variety of animal models, some of which are listed in Table 3 [21,22,75,90,102,103,104,105,106,107]. This list is by no means complete and is expected to grow rapidly as nutritional interventions recently started to gain importance in the field of DOHaD research [108].
Reprogramming strategies can be created based on the above-mentioned mechanisms leading to programmed hypertension. The reduced nephron number was restored by citrulline supplementation in the caloric restriction model [22]. The beneficial effects of citrulline [22,75], micronutrients [21], conjugated linoleic acid [106], and folic acid [107] on hypertension are related to reduction of oxidative stress. On the other hand, branched-chain amino acid supplementation prevented hypertension related to regulation of the RAS in the caloric restriction model [104]. Furthermore, maternal administration of inulin prevented adult rat offspring against high-fructose diet-induced programmed hypertension associated with nutrient-sensing signals [90].
Most reprogramming strategies have been directed at amino acids, including glycine [109], citrulline [22,75,102,103], branched-chain amino acid [104], and taurine [105]. Amino acids are building blocks of proteins and, hence, play crucial roles in organogenesis and fetal development. Glycine and vitamins (folic acid, vitamin B2, B6 and B12) take part in one-carbon metabolism and DNA methylation. Thus, glycine supplementation may have important implications for fetal programming through epigenetic mechanisms. Although a methyl-donor diet could be used for prevention of various human diseases [110], our recent study demonstrated that a maternal methyl-donor diet causes programmed hypertension in adult offspring [29]. Next, citrulline supplementation has been documented to be protective on adult offspring against hypertension in different models, including maternal caloric restriction [22], maternal NO deficiency [75], streptozotocin-induced diabetes [89], and prenatal dexamethasone exposure [103]. Citrulline supplementation is proposed to increase de novo synthesis of arginine (the substrate for nitric oxide synthase) and prevent NO deficiency [111]. Although postnatal arginine supplementation has been reported to prevent the development of hypertension in intrauterine restricted rats [112], the reprogramming effects of maternal arginine supplementation have not been examined in various models of programmed hypertension. Given that citrulline is mainly taken up by the kidney to generate arginine and that citrulline can also prevent some of the untoward effects of arginine supplementation, a better understanding of maternal citrulline supplementation in the prevention of programmed hypertension in other animal models is warranted before it is implemented in humans. Additionally, maternal branched-chain amino acid supplementation prevents developmental hypertension in adult rat offspring [104]. However, a previous report indicated that the dietary amino acid pattern, rich in branched chain amino acids, could increase the risk of hypertension [113]. Moreover, maternal taurine supplementation prevented maternal diabetes-induced programmed hypertension [105]. Taurine is an abundant semi-essential, sulfur-containing amino acid. It is well known to lower BP and increase hydrogen sulfide in established hypertensive models [114]. Since current evidence supports hydrogen sulfide as a reprogramming strategy for long-term protection against hypertension [115], whether the protective effects of maternal taurine supplementation on programmed hypertension is related to hydrogen sulfide pathway deserve further elucidation in other programming models. In addition to amino acids among macronutrients, only one report showed maternal conjugated linoleic acid supplementation has reprograming effects against hypertension [106]. Although long chain polyunsaturated fatty acids have been recommended for pregnant and breastfeeding women [101], their effects on programed hypertension remain to be determined. Next, two reports demonstrated reprogramming effects of micronutrients on programmed hypertension [21,107]. These micronutrients contain vitamin C, E, selenium, and folic acid. Vitamin C, E, and selenium have antioxidant properties. Folic acid is involved in DNA methylation. These micronutrients were shown to prevent programmed hypertension by restoring NO and reducing oxidative stress [21,107]. Furthermore, non-essential nutrients could be reprogramming strategies to prevent programmed hypertension. Maternal supplementation with dietary fiber was reported to prevent programmed hypertension in adult offspring born to dams fed with high-fructose diet [89]. Although combined supplementations with high-fiber diet and short-chain fatty acid acetate prevent hypertension in deoxycorticosterone acetate (DOCA)–salt hypertensive mice [116], their reprogramming effects on models of developmental programming awaits further elucidation. Considering that the gut microbiota dysbiosis has been associated with hypertension, supplementation with prebiotics or other nutritional interventions targeting the microbiota could be used as a reprogramming strategy.
Moreover, growing evidence from animal studies suggests that sex differences in the kidney could be a key factor in the developmental programming of hypertension [92,93]. Further work is warranted to recognize the influences of sex differences on programmed hypertension that will aid in developing novel sex-specific strategies to prevent hypertension of developmental origin in both sexes.

6. Conclusions

Maternal nutrition is like a double-edged sword. A growing body of evidence suggest that supplementation with specific macro- and micro-nutrients, and even non-essential nutrients in pregnancy and lactation protect adult offspring against hypertension in a variety of models of developmental origins. Yet, at the same time, it needs to be aware that unbalanced maternal nutrition not only affects maternal health, it also has an impact on fetal programming leading to programmed hypertension. Nutritional intervention as a reprogramming strategy against the development of hypertension is a great opportunity and will become even more crucial with the growing epidemic of hypertension and related disorders. These strategies have been proven effective in animal models, as shown earlier. A better understanding of mechanisms underlying nutritional programming is urgently needed before these interventions are implemented in humans.

Author Contributions

C.-N.H.: contributed to concept generation, data interpretation, drafting of the manuscript, critical revision of the manuscript, and approval of the article; Y.-L.T.: contributed to concept generation, data interpretation, drafting of the manuscript, critical revision of the manuscript, and approval of the article.

Funding

This research was supported by grant MOST 107-2314-B-182-045-MY3 from the Ministry of Science and Technology, Taiwan, and the grants CMRPG8G0672 and CMRPG8F0023 from Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Luyckx, V.A.; Bertram, J.F.; Brenner, B.M.; Fall, C.; Hoy, W.E.; Ozanne, S.E.; Vikse, B.E. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013, 382, 273–283. [Google Scholar] [CrossRef] [Green Version]
  2. Bagby, S.P. Maternal nutrition, low nephron number, and hypertension in later life: Pathways of nutritional programming. J. Nutr. 2007, 137, 1066–1072. [Google Scholar] [CrossRef]
  3. Hanson, M. The birth and future health of DOHaD. J. Dev. Orig. Health Dis. 2015, 6, 434–437. [Google Scholar] [CrossRef]
  4. Tain, Y.L.; Joles, J.A. Reprogramming: A preventive strategy in hypertension focusing on the kidney. Int. J. Mol. Sci. 2015, 17, 23. [Google Scholar] [CrossRef]
  5. Paauw, N.D.; van Rijn, B.B.; Lely, A.T.; Joles, J.A. Pregnancy as a critical window for blood pressure regulation in mother and child: Programming and reprogramming. Acta Physiol. 2017, 219, 241–259. [Google Scholar] [CrossRef]
  6. Nüsken, E.; Dötsch, J.; Weber, L.T.; Nüsken, K.D. Developmental programming of renal function and re-programming approaches. Front. Pediatr. 2018, 6, 36. [Google Scholar] [CrossRef]
  7. Schulz, L.C. The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. USA 2010, 107, 16757–16758. [Google Scholar] [CrossRef] [Green Version]
  8. Hult, M.; Tornhammar, P.; Ueda, P.; Chima, C.; Bonamy, A.K.; Ozumba, B.; Norman, M. Hypertension, diabetes and overweight: Looming legacies of the Biafran famine. PLoS ONE 2010, 5, e13582. [Google Scholar] [CrossRef]
  9. Stein, A.D.; Zybert, P.A.; van der Pal-de Bruin, K.; Lumey, L.H. Exposure to famine during gestation, size at birth, and blood pressure at age 59 y: Evidence from the Dutch Famine. Eur. J. Epidemiol. 2006, 21, 759–765. [Google Scholar] [CrossRef]
  10. Bertagnolli, M.; Luu, T.M.; Lewandowski, A.J.; Leeson, P.; Nuyt, A.M. Preterm birth and hypertension: Is there a link? Curr. Hypertens. Rep. 2016, 18, 28. [Google Scholar] [CrossRef]
  11. de Jong, F.; Monuteaux, M.C.; van Elburg, R.M.; Gillman, M.W.; Belfort, M.B. Systematic review and meta-analysis of preterm birth and later systolic blood pressure. Hypertension 2012, 59, 226–234. [Google Scholar] [CrossRef] [PubMed]
  12. Bloomfield, F.H. How is maternal nutrition related to preterm birth? Annu. Rev. Nutr. 2011, 31, 235–261. [Google Scholar] [CrossRef]
  13. Hrudey, E.J.; Reynolds, R.M.; Oostvogels, A.J.; Brouwer, I.A.; Vrijkotte, T.G. The association between maternal 25-hydroxyvitamin D concentration during gestation and early childhood cardio-metabolic outcomes: Is there interaction with pre-pregnancy BMI? PLoS ONE 2015, 10, e0133313. [Google Scholar] [CrossRef]
  14. Williams, D.M.; Fraser, A.; Fraser, W.D.; Hyppönen, E.; Davey Smith, G.; Deanfield, J.; Hingorani, A.; Sattar, N.; Lawlor, D.A. Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: Findings from the Avon Longitudinal Study of Parents and Children. Heart 2013, 99, 1849–1856. [Google Scholar] [CrossRef]
  15. Hosaka, M.; Asayama, K.; Staessen, J.A.; Ohkubo, T.; Hayashi, K.; Tatsuta, N.; Kurokawa, N.; Satoh, M.; Hashimoto, T.; Hirose, T.; et al. Breastfeeding leads to lower blood pressure in 7-year-old Japanese children: Tohoku study of child development. Hypertens. Res. 2013, 36, 117–122. [Google Scholar] [CrossRef]
  16. Tam, W.H.; Ma, R.C.W.; Ozaki, R.; Li, A.M.; Chan, M.H.M.; Yuen, L.Y.; Lao, T.T.H.; Yang, X.; Ho, C.S.; Tutino, G.E.; et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care 2017, 40, 679–686. [Google Scholar] [CrossRef] [PubMed]
  17. Fraser, A.; Tilling, K.; Macdonald-Wallis, C.; Sattar, N.; Brion, M.J.; Benfield, L.; Ness, A.; Deanfield, J.; Hingorani, A.; Nelson, S.M.; et al. Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation 2010, 121, 2557–2564. [Google Scholar] [CrossRef] [PubMed]
  18. Mamun, A.A.; O’Callaghan, M.; Callaway, L.; Williams, G.; Najman, J.; Lawlor, D.A. Associations of gestational weight gain with offspring body mass index and blood pressure at 21 years of age: Evidence from a birth cohort study. Circulation 2009, 119, 1720–1727. [Google Scholar] [CrossRef]
  19. Hrolfsdottir, L.; Halldorsson, T.I.; Rytter, D.; Bech, B.H.; Birgisdottir, B.E.; Gunnarsdottir, I.; Granström, C.; Henriksen, T.B.; Olsen, S.F.; Maslova, E. Maternal macronutrient intake and offspring blood pressure 20 years later. J. Am. Heart Assoc. 2017, 6, e005808. [Google Scholar] [CrossRef]
  20. Woodall, S.M.; Johnston, B.M.; Breier, B.H.; Gluckman, P.D. Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr. Res. 1996, 40, 438–443. [Google Scholar] [CrossRef]
  21. Franco Mdo, C.; Ponzio, B.F.; Gomes, G.N.; Gil, F.Z.; Tostes, R.; Carvalho, M.H.; Fortes, Z.B. Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition. Life Sci. 2009, 85, 327–333. [Google Scholar] [CrossRef] [PubMed]
  22. Tain, Y.L.; Hsieh, C.S.; Lin, I.C.; Chen, C.C.; Sheen, J.M.; Huang, L.T. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: The impact of nitric oxide pathway. Nitric Oxide 2010, 23, 34–41. [Google Scholar] [CrossRef] [PubMed]
  23. Ozaki, T.; Nishina, H.; Hanson, M.A.; Poston, L. Dietary restriction in pregnant rats causes gender-related hypertension and vascular dysfunction in offspring. J. Physiol. 2001, 530, 141–152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Sathishkumar, K.; Elkins, R.; Yallampalli, U.; Yallampalli, C. Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J. Vasc. Res. 2009, 46, 229–239. [Google Scholar] [CrossRef] [PubMed]
  25. Woods, L.L.; Ingelfinger, J.R.; Nyengaard, J.R.; Rasch, R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr. Res. 2001, 49, 460–467. [Google Scholar] [CrossRef] [PubMed]
  26. Cambonie, G.; Comte, B.; Yzydorczyk, C.; Ntimbane, T.; Germain, N.; Lê, N.L.; Pladys, P.; Gauthier, C.; Lahaie, I.; Abran, D.; et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R1236–R1245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Bai, S.Y.; Briggs, D.I.; Vickers, M.H. Increased systolic blood pressure in rat offspring following a maternal low-protein diet is normalized by maternal dietary choline supplementation. J. Dev. Orig. Health Dis. 2012, 3, 342–349. [Google Scholar] [CrossRef] [PubMed]
  28. Goyal, R.; Van-Wickle, J.; Goyal, D.; Longo, L.D. Antenatal maternal low protein diet: ACE-2 in the mouse lung and sexually dimorphic programming of hypertension. BMC Physiol. 2015, 15, 2. [Google Scholar] [CrossRef] [PubMed]
  29. Tain, Y.L.; Chan, J.Y.H.; Lee, C.T.; Hsu, C.N. Maternal melatonin therapy attenuates methyl-donor diet-induced programmed hypertension in male adult rat offspring. Nutrients 2018, 10, 1407. [Google Scholar] [CrossRef]
  30. Resende, A.C.; Emiliano, A.F.; Cordeiro, V.S.; de Bem, G.F.; de Cavalho, L.C.; de Oliveira, P.R.; Neto, M.L.; Costa, C.A.; Boaventura, G.T.; de Moura, R.S. Grape skin extract protects against programmed changes in the adult rat offspring caused by maternal high-fat diet during lactation. J. Nutr. Biochem. 2013, 24, 2119–2126. [Google Scholar] [CrossRef] [PubMed]
  31. Khan, I.Y.; Taylor, P.D.; Dekou, V.; Seed, P.T.; Lakasing, L.; Graham, D.; Dominiczak, A.F.; Hanson, M.A.; Poston, L. Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension 2003, 41, 168–175. [Google Scholar] [CrossRef] [PubMed]
  32. Torrens, C.; Ethirajan, P.; Bruce, K.D.; Cagampang, F.R.; Siow, R.C.; Hanson, M.A.; Byrne, C.D.; Mann, G.E.; Clough, G.F. Interaction between maternal and offspring diet to impair vascular function and oxidative balance in high fat fed male mice. PLoS ONE 2012, 7, e50671. [Google Scholar] [CrossRef]
  33. Tain, Y.L.; Lin, Y.J.; Sheen, J.M.; Yu, H.R.; Tiao, M.M.; Chen, C.C.; Tsai, C.C.; Huang, L.T.; Hsu, C.N. High fat diets sex-specifically affect the renal transcriptome and program obesity, kidney injury, and hypertension in the offspring. Nutrients 2017, 9, 357. [Google Scholar] [CrossRef]
  34. Wu, L.; Shi, A.; Zhu, D.; Bo, L.; Zhong, Y.; Wang, J.; Xu, Z.; Mao, C. High sucrose intake during gestation increases angiotensin II type 1 receptor-mediated vascular contractility associated with epigenetic alterations in aged offspring rats. Peptides 2016, 86, 133–144. [Google Scholar] [CrossRef] [PubMed]
  35. Gray, C.; Gardiner, S.M.; Elmes, M.; Gardner, D.S. Excess maternal salt or fructose intake programmes sex-specific, stress- and fructose-sensitive hypertension in the offspring. Br. J. Nutr. 2016, 115, 594–604. [Google Scholar] [CrossRef]
  36. Tain, Y.L.; Wu, K.L.; Lee, W.C.; Leu, S.; Chan, J.Y. Maternal fructose-intake-induced renal programming in adult male offspring. J. Nutr. Biochem. 2015, 26, 642–650. [Google Scholar] [CrossRef] [PubMed]
  37. Hsu, C.N.; Wu, K.L.; Lee, W.C.; Leu, S.; Chan, J.Y.; Tain, Y.L. Aliskiren administration during early postnatal life sex-specifically alleviates hypertension programmed by maternal high fructose consumption. Front. Physiol. 2016, 7, 299. [Google Scholar] [CrossRef]
  38. Yamada-Obara, N.; Yamagishi, S.I.; Taguchi, K.; Kaida, Y.; Yokoro, M.; Nakayama, Y.; Ando, R.; Asanuma, K.; Matsui, T.; Ueda, S.; et al. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin. Exp. Nephrol. 2016, 20, 853–886. [Google Scholar] [CrossRef]
  39. Saad, A.F.; Dickerson, J.; Kechichian, T.B.; Yin, H.; Gamble, P.; Salazar, A.; Patrikeev, I.; Motamedi, M.; Saade, G.R.; Costantine, M.M. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring. Am. J. Obstet. Gynecol. 2016, 215, e1–e6. [Google Scholar] [CrossRef] [PubMed]
  40. Gray, C.; Harrison, C.J.; Segovia, S.A.; Reynolds, C.M.; Vickers, M.H. Maternal salt and fat intake causes hypertension and sustained endothelial dysfunction in fetal, weanling and adult male resistance vessels. Sci. Rep. 2015, 5, 9753. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Koleganova, N.; Piecha, G.; Ritz, E.; Becker, L.E.; Müller, A.; Weckbach, M.; Nyengaard, J.R.; Schirmacher, P.; Gross-Weissmann, M.L. Both high and low maternal salt intake in pregnancy alter kidney development in the offspring. Am. J. Physiol. Renal Physiol. 2011, 301, F344–F354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Bergel, E.; Belizán, J.M. A deficient maternal calcium intake during pregnancy increases blood pressure of the offspring in adult rats. BJOG 2002, 109, 540–545. [Google Scholar] [CrossRef] [PubMed]
  43. Schlegel, R.N.; Moritz, K.M.; Paravicini, T.M. Maternal hypomagnesemia alters renal function but does not program changes in the cardiovascular physiology of adult offspring. J. Dev. Orig. Health Dis. 2016, 7, 473–480. [Google Scholar] [CrossRef] [PubMed]
  44. Gambling, L.; Dunford, S.; Wallace, D.I.; Zuur, G.; Solanky, N.; Srai, K.S.; McArdle, H.J. Iron deficiency during pregnancy affects post-natal blood pressure in the rat. J. Physiol. 2003, 552, 603–610. [Google Scholar] [CrossRef] [PubMed]
  45. Lewis, R.M.; Petry, C.J.; Ozanne, S.E.; Hales, C.N. Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance, and serum lipids in the 3-month-old offspring. Metabolism 2001, 50, 562–567. [Google Scholar] [CrossRef] [PubMed]
  46. Tare, M.; Emmett, S.J.; Coleman, H.A.; Skordilis, C.; Eyles, D.W.; Morley, R.; Parkington, H.C. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J. Physiol. 2011, 589, 4777–4786. [Google Scholar] [CrossRef] [Green Version]
  47. Tomat, A.; Elesgaray, R.; Zago, V.; Fasoli, H.; Fellet, A.; Balaszczuk, A.M.; Schreier, L.; Costa, M.A.; Arranz, C. Exposure to zinc deficiency in fetal and postnatal life determines nitric oxide system activity and arterial blood pressure levels in adult rats. Br. J. Nutr. 2010, 104, 382–389. [Google Scholar] [CrossRef] [Green Version]
  48. Sengupta, P. The Laboratory Rat: Relating Its Age with Human’s. Int. J. Prev. Med. 2013, 4, 624–630. [Google Scholar]
  49. Langley-Evans, S.C. Critical differences between two low protein diet protocols in the programming of hypertension in the rat. Int. J. Food Sci. Nutr. 2000, 51, 11–17. [Google Scholar] [CrossRef]
  50. O’Neill, R.J.; Vrana, P.B.; Rosenfeld, C.S. Maternal methyl supplemented diets and effects on offspring health. Front. Genet. 2014, 5, 289. [Google Scholar] [CrossRef]
  51. Buettner, R.; Schölmerich, J.; Bollheimer, L.C. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15, 798–808. [Google Scholar] [CrossRef]
  52. Williams, L.; Seki, Y.; Vuguin, P.M.; Charron, M.J. Animal models of in utero exposure to a high fat diet: A review. Biochim. Biophys. Acta 2014, 1842, 507–519. [Google Scholar] [CrossRef]
  53. Vos, M.B.; Kimmons, J.E.; Gillespie, C.; Welsh, J.; Blanck, H.M. Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape J. Med. 2008, 10, 160. [Google Scholar] [PubMed]
  54. Lee, W.C.; Wu, K.L.H.; Leu, S.; Tain, Y.L. Translational insights on developmental origins of metabolic syndrome: Focus on fructose consumption. Biomed. J. 2018, 41, 96–101. [Google Scholar] [CrossRef]
  55. Tain, Y.L.; Lee, W.C.; Leu, S.; Wu, K.; Chan, J. High salt exacerbates programmed hypertension in maternal fructose-fed male offspring. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 1146–1151. [Google Scholar] [CrossRef] [PubMed]
  56. Tain, Y.L.; Lee, W.C.; Wu, K.; Leu, S.; Chan, J.Y.H. Maternal high fructose intake increases the vulnerability to post-weaning high-fat diet induced programmed hypertension in male offspring. Nutrients 2018, 10, 56. [Google Scholar] [CrossRef]
  57. Houston, M.C. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther. Adv. Cardiovasc. Dis. 2010, 4, 165–183. [Google Scholar] [CrossRef] [PubMed]
  58. Mossa, F.; Carter, F.; Walsh, S.W.; Kenny, D.A.; Smith, G.W.; Ireland, J.L.; Hildebrandt, T.B.; Lonergan, P.; Ireland, J.J.; Evans, A.C. Maternal undernutrition in cows impairs ovarian and cardiovascular systems in their offspring. Biol. Reprod. 2013, 88, 92. [Google Scholar] [CrossRef] [PubMed]
  59. Gilbert, J.S.; Lang, A.L.; Grant, A.R.; Nijland, M.J. Maternal nutrient restriction in sheep: Hypertension and decreased nephron number in offspring at 9 months of age. J. Physiol. 2005, 565, 137–147. [Google Scholar] [CrossRef] [PubMed]
  60. Langley-Evans, S.C. Nutritional programming of disease: Unravelling the mechanism. J. Anat. 2009, 215, 36–51. [Google Scholar] [CrossRef]
  61. Ojeda, N.B.; Grigore, D.; Alexander, B.T. Developmental programming of hypertension: Insight from animal models of nutritional manipulation. Hypertension 2008, 52, 44–50. [Google Scholar] [CrossRef] [PubMed]
  62. Tain, Y.L.; Hsu, C.N.; Chan, J.Y.; Huang, L.T. Renal Transcriptome analysis of programmed hypertension induced by maternal nutritional insults. Int. J. Mol. Sci. 2015, 16, 17826–17837. [Google Scholar] [CrossRef] [PubMed]
  63. Yang, T.; Santisteban, M.M.; Rodriguez, V.; Li, E.; Ahmari, N.; Carvajal, J.M.; Zadeh, M.; Gong, M.; Qi, Y.; Zubcevic, J.; et al. Gut dysbiosis is linked to hypertension. Hypertension 2015, 65, 1331–1340. [Google Scholar] [CrossRef] [PubMed]
  64. Tain, Y.L.; Hsu, C.N. Interplay between oxidative stress and nutrient sensing signaling in the developmental origins of cardiovascular disease. Int. J. Mol. Sci. 2017, 18, 841. [Google Scholar] [CrossRef] [PubMed]
  65. Wood-Bradley, R.J.; Barrand, S.; Giot, A.; Armitage, J.A. Understanding the role of maternal diet on kidney development; an opportunity to improve cardiovascular and renal health for future generations. Nutrients 2015, 7, 1881–1905. [Google Scholar] [CrossRef] [PubMed]
  66. Gurusinghe, S.; Tambay, A.; Sethna, C.B. Developmental Origins and Nephron Endowment in Hypertension. Front. Pediatr. 2017, 5, 151. [Google Scholar] [CrossRef] [PubMed]
  67. Tain, Y.L.; Hsu, C.N. Developmental origins of chronic kidney disease: Should we focus on early life? Int. J. Mol. Sci. 2017, 18, 381. [Google Scholar] [CrossRef] [PubMed]
  68. Luzardo, R.; Silva, P.A.; Einicker-Lamas, M.; Ortiz-Costa, S.; do Carmo Mda, G.; Vieira-Filho, L.D.; Paixão, A.D.; Lara, L.S.; Vieyra, A. Metabolic programming during lactation stimulates renal Na+ transport in the adult offspring due to an early impact on local angiotensin II pathways. PLoS ONE 2011, 6, e21232. [Google Scholar] [CrossRef] [PubMed]
  69. Lelièvre-Pégorier, M.; Vilar, J.; Ferrier, M.L.; Moreau, E.; Freund, N.; Gilbert, T.; Merlet-Bénichou, C. Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int. 1998, 54, 1455–1462. [Google Scholar] [CrossRef] [PubMed]
  70. Lisle, S.J.; Lewis, R.M.; Petry, C.J.; Ozanne, S.E.; Hales, C.N.; Forhead, A.J. Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br. J. Nutr. 2003, 90, 33–39. [Google Scholar] [CrossRef] [Green Version]
  71. Hokke, S.; Puelles, V.G.; Armitage, J.A.; Fong, K.; Bertram, J.F.; Cullen-McEwen, L.A. Maternal fat feeding augments offspring nephron endowment in mice. PLoS ONE 2016, 11, e0161578. [Google Scholar] [CrossRef] [PubMed]
  72. Woods, L.L.; Ingelfinger, J.R.; Rasch, R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R1131–R1136. [Google Scholar] [CrossRef] [PubMed]
  73. Wu, G.; Bazer, F.W.; Cudd, T.A.; Meininger, C.J.; Spencer, T.E. Maternal nutrition and fetal development. J. Nutr. 2004, 134, 2169–2172. [Google Scholar] [CrossRef] [PubMed]
  74. Avila, J.G.; Echeverri, I.; de Plata, C.A.; Castillo, A. Impact of oxidative stress during pregnancy on fetal epigenetic patterns and early origin of vascular diseases. Nutr. Rev. 2015, 73, 12–21. [Google Scholar] [CrossRef] [PubMed]
  75. Tain, Y.L.; Huang, L.T.; Lee, C.T.; Chan, J.Y.; Hsu, C.N. Maternal citrulline supplementation prevents prenatal NG-nitro-l-arginine-methyl ester (L-NAME)-induced programmed hypertension in rats. Biol. Reprod. 2015, 92, 7. [Google Scholar] [CrossRef]
  76. Tain, Y.L.; Hsu, C.N. Targeting on asymmetric dimethylarginine related nitric oxide-reactive oxygen species imbalance to reprogram the development of hypertension. Int. J. Mol. Sci. 2016, 17, 2020. [Google Scholar] [CrossRef] [PubMed]
  77. Yosypiv, I.V. Renin-angiotensin system in ureteric bud branching morphogenesis: Insights into the mechanisms. Pediatr. Nephrol. 2011, 26, 1499–1512. [Google Scholar] [CrossRef] [PubMed]
  78. Sherman, R.C.; Langley-Evans, S.C. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin. Sci. 2000, 98, 269–275. [Google Scholar] [CrossRef] [PubMed]
  79. Hsu, C.N.; Lee, C.T.; Huang, L.T.; Tain, Y.L. Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction. J. Renin Angiotensin Aldosterone Syst. 2015, 16, 506–513. [Google Scholar] [CrossRef] [PubMed]
  80. Efeyan, A.; Comb, W.C.; Sabatini, D.M. Nutrient-sensing mechanisms and pathways. Nature 2015, 517, 302–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  81. Tain, Y.L.; Hsu, C.N.; Chan, J.Y. PPARs link early life nutritional insults to later programmed hypertension and metabolic syndrome. Int. J. Mol. Sci. 2015, 17, 20. [Google Scholar] [CrossRef] [PubMed]
  82. Polvani, S.; Tarocchi, M.; Galli, A. PPARγ and oxidative stress: Con(β) catenating NRF2 and FOXO. PPAR Res. 2012, 2012, 641087. [Google Scholar] [CrossRef] [PubMed]
  83. Todorov, V.T.; Desch, M.; Schmitt-Nilson, N.; Todorova, A.; Kurtz, A. Peroxisome proliferator-activated receptor-γ is involved in the control of renin gene expression. Hypertension 2007, 50, 939–944. [Google Scholar] [CrossRef] [PubMed]
  84. Saad, S.; Agapiou, D.J.; Chen, X.M.; Stevens, V.; Pollock, C.A. The role of Sgk-1 in the upregulation of transport proteins by PPAR-γ agonists in human proximal tubule cells. Nephrol. Dial. Transplant. 2009, 24, 1130–1141. [Google Scholar] [CrossRef] [PubMed]
  85. Tain, Y.L.; Hsu, C.N. AMP-Activated protein kinase as a reprogramming strategy for hypertension and kidney disease of developmental origin. Int. J. Mol. Sci. 2018, 19, 1744. [Google Scholar] [CrossRef] [PubMed]
  86. Chu, D.M.; Meyer, K.M.; Prince, A.L.; Aagaard, K.M. Impact of maternal nutrition in pregnancy and lactation on offspring gut microbial composition and function. Gut Microbes 2016, 7, 459–470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Ma, J.; Li, H. The role of gut microbiota in atherosclerosis and hypertension. Front. Pharmacol. 2018, 9, 1082. [Google Scholar] [CrossRef] [PubMed]
  88. Tain, Y.L.; Lee, W.C.; Wu, K.L.H.; Leu, S.; Chan, J.Y.H. Resveratrol prevents the development of hypertension programmed by maternal plus post-weaning high-fructose consumption through modulation of oxidative stress, nutrient-sensing signals, and gut microbiota. Mol. Nutr. Food Res. 2018, 62, e1800066. [Google Scholar] [CrossRef]
  89. Al Khodor, S.; Reichert, B.; Shatat, I.F. The microbiome and blood pressure: Can microbes regulate our blood pressure? Front. Pediatr. 2017, 5, 138. [Google Scholar] [CrossRef] [PubMed]
  90. Hsu, C.N.; Lin, Y.J.; Hou, C.Y.; Tain, Y.L. Maternal administration of probiotic or prebiotic prevents male adult rat offspring against developmental programming of hypertension induced by high fructose consumption in pregnancy and lactation. Nutrients 2018, 10, 1229. [Google Scholar] [CrossRef] [PubMed]
  91. Lankelma, J.M.; Nieuwdorp, M.; de Vos, W.M.; Wiersinga, W.J. The gut microbiota in internal medicine: Implications for health and disease. Neth. J. Med. 2015, 73, 61–68. [Google Scholar] [PubMed]
  92. Tomat, A.L.; Salazar, F.J. Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences. Horm. Mol. Biol. Clin. Investig. 2014, 18, 63–77. [Google Scholar] [CrossRef] [PubMed]
  93. Ojeda, N.B.; Intapad, S.; Alexander, B.T. Sex differences in the developmental programming of hypertension. Acta Physiol. 2014, 210, 307–316. [Google Scholar] [CrossRef] [PubMed]
  94. Vina, J.; Gambini, J.; Lopez-Grueso, R.; Abdelaziz, K.M.; Jove, M.; Borras, C. Females live longer than males: Role of oxidative stress. Curr. Pharm. Des. 2011, 17, 3959–3965. [Google Scholar] [CrossRef] [PubMed]
  95. Hilliard, L.M.; Sampson, A.K.; Brown, R.D.; Denton, K.M. The “his and hers” of the renin-angiotensin system. Curr. Hypertens. Rep. 2013, 15, 71–79. [Google Scholar] [CrossRef] [PubMed]
  96. Tain, Y.L.; Huang, L.T.; Chan, J.Y.; Lee, C.T. Transcriptome analysis in rat kidneys: Importance of genes involved in programmed hypertension. Int. J. Mol. Sci. 2015, 16, 4744–4758. [Google Scholar] [CrossRef] [PubMed]
  97. Mao, J.; Zhang, X.; Sieli, P.T.; Falduto, M.T.; Torres, K.E.; Rosenfeld, C.S. Contrasting effects of different maternal diets on sexually dimorphic gene expression in the murine placenta. Proc. Natl. Acad. Sci. USA 2010, 107, 5557–5562. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Cheong, J.N.; Wlodek, M.E.; Moritz, K.M.; Cuffe, J.S. Programming of maternal and offspring disease: Impact of growth restriction, fetal sex and transmission across generations. J. Physiol. 2016, 594, 4727–4740. [Google Scholar] [CrossRef] [Green Version]
  99. Ota, E.; Hori, H.; Mori, R.; Tobe-Gai, R.; Farrar, D. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst. Rev. 2015, 6, CD000032. [Google Scholar] [CrossRef]
  100. Haider, B.A.; Bhutta, Z.A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst. Rev. 2017, 4, CD004905. [Google Scholar] [CrossRef]
  101. Schwarzenberg, S.J.; Georgieff, M.K.; COMMITTEE ON NUTRITION. Advocacy for improving nutrition in the first 1000 days to support childhood development and adult health. Pediatrics 2018, 141, e20173716. [Google Scholar] [CrossRef]
  102. Tain, Y.L.; Lee, W.C.; Hsu, C.N.; Lee, W.C.; Huang, L.T.; Lee, C.T.; Lin, C.Y. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. PLoS ONE 2013, 8, e55420. [Google Scholar] [CrossRef] [PubMed]
  103. Tain, Y.L.; Sheen, J.M.; Chen, C.C.; Yu, H.R.; Tiao, M.M.; Kuo, H.C.; Huang, L.T. Maternal citrulline supplementation prevents prenatal dexamethasone-induced programmed hypertension. Free Radic. Res. 2014, 48, 580–586. [Google Scholar] [CrossRef] [PubMed]
  104. Fujii, T.; Yura, S.; Tatsumi, K.; Kondoh, E.; Mogami, H.; Fujita, K.; Kakui, K.; Aoe, S.; Itoh, H.; Sagawa, N.; et al. Branched-chain amino acid supplemented diet during maternal food restriction prevents developmental hypertension in adult rat offspring. J. Dev. Orig. Health Dis. 2011, 2, 176–183. [Google Scholar] [CrossRef] [PubMed]
  105. Thaeomor, A.; Teangphuck, P.; Chaisakul, J.; Seanthaweesuk, S.; Somparn, N.; Roysommuti, S. Perinatal Taurine Supplementation Prevents Metabolic and Cardiovascular Effects of Maternal Diabetes in Adult Rat Offspring. Adv. Exp. Med. Biol. 2017, 975, 295–305. [Google Scholar]
  106. Gray, C.; Vickers, M.H.; Segovia, S.A.; Zhang, X.D.; Reynolds, C.M. A maternal high fat diet programmes endothelial function and cardiovascular status in adult male offspring independent of body weight, which is reversed by maternal conjugated linoleic acid (CLA) supplementation. PLoS ONE 2015, 10, e0115994. [Google Scholar] [CrossRef]
  107. Torrens, C.; Brawley, L.; Anthony, F.W.; Dance, C.S.; Dunn, R.; Jackson, A.A.; Poston, L.; Hanson, M.A. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension 2006, 47, 982–987. [Google Scholar] [CrossRef]
  108. Ji, Y.; Wu, Z.; Dai, Z.; Sun, K.; Wang, J.; Wu, G. Nutritional epigenetics with a focus on amino acids: Implications for the development and treatment of metabolic syndrome. J. Nutr. Biochem. 2016, 27, 1–8. [Google Scholar] [CrossRef]
  109. Jackson, A.A.; Dunn, R.L.; Marchand, M.C.; Langley-Evans, S.C. Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin. Sci. 2002, 103, 633–639. [Google Scholar] [CrossRef] [Green Version]
  110. Glier, M.B.; Green, T.J.; Devlin, A.M. Methyl nutrients, DNA methylation, and cardiovascular disease. Mol. Nutr. Food Res. 2014, 58, 172–182. [Google Scholar] [CrossRef]
  111. Romero, M.J.; Platt, D.H.; Caldwell, R.B.; Caldwell, R.W. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc. Drug Rev. 2006, 24, 275–290. [Google Scholar] [CrossRef]
  112. Alves, G.M.; Barão, M.A.; Odo, L.N.; Nascimento Gomes, G.; Franco Md Mdo, C.; Nigro, D.; Lucas, S.R.; Laurindo, F.R.; Brandizzi, L.I.; Zaladek Gil, F. L-Arginine effects on blood pressure and renal function of intrauterine restricted rats. Pediatr. Nephrol. 2002, 17, 856–862. [Google Scholar] [CrossRef] [PubMed]
  113. Teymoori, F.; Asghari, G.; Mirmiran, P.; Azizi, F. Dietary amino acids and incidence of hypertension: A principle component analysis approach. Sci. Rep. 2017, 7, 16838. [Google Scholar] [CrossRef] [Green Version]
  114. Militante, J.D.; Lombardini, J.B. Treatment of hypertension with oral taurine: Experimental and clinical studies. Amino Acids 2002, 23, 381–393. [Google Scholar] [CrossRef] [PubMed]
  115. Hsu, C.N.; Tain, Y.L. Hydrogen sulfide in hypertension and kidney disease of developmental origins. Int. J. Mol. Sci. 2018, 19, 1438. [Google Scholar] [CrossRef]
  116. Marques, F.Z.; Nelson, E.; Chu, P.Y.; Horlock, D.; Fiedler, A.; Ziemann, M.; Tan, J.K.; Kuruppu, S.; Rajapakse, N.W.; El-Osta, A.; et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 2017, 135, 964–977. [Google Scholar] [CrossRef] [PubMed]
Nutrients 10 01917 g001 550
Figure 1. Schematic illustration of the double-edged sword effects of maternal nutrition and common mechanisms underlying the developmental programming of hypertension.
Figure 1. Schematic illustration of the double-edged sword effects of maternal nutrition and common mechanisms underlying the developmental programming of hypertension.
Nutrients 10 01917 g001
Table
Table 1. Effects of maternal nutrition on offspring blood pressure in human cohort studies.
Table 1. Effects of maternal nutrition on offspring blood pressure in human cohort studies.
Cohort StudyOffspring, nAge Range, YearCountryRisk Factors
ABCD [13]18345–6NetherlandsVitamin D deficiency
Tohoku Study of Child Development [15]3777JapanShort-term breastfeeding
Hyperglycemia and Adverse Pregnancy Outcome study [16]9707Hong KongGestational diabetes mellitus
ALSPAC [14]35259.9United KingdomVitamin D deficiency
ALSPAC [17]220016United KingdomExcessive gestational weight gain
DaFO88 [19]434 20ScotlandMacronutrient intake deficiency
MUSP [18]227121AustraliaExcessive gestational weight gain
Dutch Famine study [9]35959NetherlandsUndernutrition
Studies tabulated according to offspring age. ABCD = Amsterdam Born Children and their Development; ALSPAC = The Avon Longitudinal Study of Parents and Children; DaFO88 = Danish Fetal Origins Cohort; MUSP = Mater-University Study of Pregnancy and its Outcomes.
Table
Table 2. Offspring blood pressure in nutritional rodent models of developmental programming.
Table 2. Offspring blood pressure in nutritional rodent models of developmental programming.
Animal ModelsIntervention PeriodSpecies/GenderAge at Measure (Week)Higher than ControlReference
Macronutrients
30% caloric restrictionPregnancyWistar/M+F54Yes[20]
50% caloric restrictionPregnancyWistar/M+F14–16Yes[21]
50% caloric restrictionPregnancy and lactationSD/M12Yes[22]
70% caloric restrictionGestation days 0–18Wistar/M+F28Yes[23]
Protein restriction, 6%PregnancySD/F52Yes[24]
Protein restriction, 8.5%PregnancySD/M20Yes[25]
Protein restriction, 9%PregnancyWistar/M12Yes[26]
Protein restriction, 9%PregnancyWistar/M+F22Yes[27]
Protein restriction, 9%1 week before conception and throughout pregnancyFVB/NJ mice/F24Yes[28]
High methyl-donor diet Pregnancy and lactationSD/M12Yes[29]
Methyl-deficient dietPregnancy and lactationSD/M12Yes[29]
High-fat diet, 24%LactationWistar/M22Yes[30]
High-fat diet, 25.7%LactationSD/M25No[31]
High-fat diet, 25.7%LactationSD/F25Yes[31]
High-fat diet, 45%Pregnancy and lactationC57BL6J mice/M30Yes[32]
High-fat diet, 58%5 weeks before the delivery and throughout pregnancy and lactationSD/M+F25No[33]
20% w/v sucrose in drinking waterPregnancySD/M90Yes[34]
10% w/v fructose plus 4% NaCl in drinking water4 weeks before conception and throughout pregnancy and lactationSD/M9Yes[35]
High-fructose diet, 60%Pregnancy and lactationSD/M+F12Yes[36,37]
High-fructose diet, 56.7% plus high-fat dietPregnancy and lactationSD/M16Yes[38]
10% w/v fructose in drinking waterPregnancy and lactationC57BL6J mice/M52Yes[39]
High-fat diet, 45% plus 4% NaCl in drinking water3 weeks before conception and throughout pregnancy and lactationSD/M19Yes[40]
Low-salt diet, 0.07%Pregnancy and lactationSD/M21Yes[41]
High-salt diet, 3%Pregnancy and lactationSD/M21Yes[41]
Calcium-deficient dietPregnancyWKY/M+F52Yes[42]
Magnesium-deficient dietPregnancyC57BL6J mice /M+F24No[43]
Micronutrients
Iron restriction4 weeks before conception and throughout pregnancyRHL/M+F10Yes[44]
Iron restriction4 weeks before conception and throughout pregnancyWistar/M+F64Yes[45]
Vitamin D restricted diet6 weeks before conception and throughout pregnancy and lactationSD/M+F7–8Yes[46]
Zinc-deficient dietPregnancy and lactationWistar/M12Yes[47]
Studies tabulated according to nutritional intervention and age at measure. SD = Sprague-Dawley rat; WKY = Wistar-Kyoto rat; M = Male; F = Female; RHL = Rowett Hooded Lister rat.
Table
Table 3. Reprogramming strategies aimed at nutritional interventions to prevent hypertension of developmental programming in animal models.
Table 3. Reprogramming strategies aimed at nutritional interventions to prevent hypertension of developmental programming in animal models.
Nutritional InterventionsAnimal ModelsIntervention PeriodSpecies/GenderAge at Measure (Week)Lower BP?Ref.
Macronutrients
GlycineMaternal 9% protein restrictionPregnancyWistar/M4Yes[109]
CitrullineMaternal 50% caloric restrictionPregnancy and lactationSD/M12Yes[22]
CitrullineMaternal nitric oxide deficiencyPregnancy and lactationSD/M12Yes[75]
CitrullineStreptozotocin-induced diabetesPregnancy and lactationSD/M12Yes[102]
CitrullinePrenatal dexamethasone exposurePregnancy and lactationSD/M12Yes[103]
Branched-chain amino acidMaternal 70% caloric restrictionPregnancySD/M16Yes[104]
TaurineStreptozotocin-induced diabetesPregnancy and lactationWistar/M+F16Yes[105]
Conjugated linoleic acidMaternal high-fat dietPregnancy and lactationSD/M18Yes[106]
Micronutrients
Micronutrients: vitamin C, E, selenium and folic acidMaternal 50% caloric restrictionPregnancyWistar/M+F14–16Yes[21]
Folic acidProtein restriction, 9%PregnancyWistar/M15Yes[107]
Non-essential nutrients
Long chain inulinMaternal high-fructose dietPregnancy and LactationSD/M12Yes[90]
Studies tabulated according to types of nutritional intervention and age at measure. SD = Sprague–Dawley rat. M = male. F = female.

Share and Cite

MDPI and ACS Style

Hsu, C.-N.; Tain, Y.-L. The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension. Nutrients 2018, 10, 1917. https://doi.org/10.3390/nu10121917

AMA Style

Hsu C-N, Tain Y-L. The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension. Nutrients. 2018; 10(12):1917. https://doi.org/10.3390/nu10121917

Chicago/Turabian Style

Hsu, Chien-Ning, and You-Lin Tain. 2018. "The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension" Nutrients 10, no. 12: 1917. https://doi.org/10.3390/nu10121917

APA Style

Hsu, C. -N., & Tain, Y. -L. (2018). The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension. Nutrients, 10(12), 1917. https://doi.org/10.3390/nu10121917

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop